Pilot study of controlled retrospective analysis (retrolective study design) of care provisions for type 2 diabetics since 1990;Pilotstudie zur kontrollierten retrospektiven analyse (retrolektives studiendesign) der versorgung des typ-2-diabetes seit 1990

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 21, 2003, Pages 1173-1178

  Martin, Stephan ^a,c   Reipen, M ^a   Van Leendert, R ^b   Beuth, J ^b   Kolb, H ^a   Scherbaum, W A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPUTATION; ARTICLE; BLINDNESS; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PILOT STUDY; RETROSPECTIVE STUDY; STROKE; ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; DIABETIC ANGIOPATHY; DIABETIC FOOT; DOCUMENTATION; GENERAL PRACTICE; MIDDLE AGED; MORTALITY; STANDARD; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOGRAPHY; BLINDNESS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DOCUMENTATION; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 0037531142     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39352     Document Type: Article

References (24)

1. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342: 1878-1886
2. Beuth J, Ost B, Pakdaman A et al. Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients - results of an epidemiological multicentre retrolective cohort study. Cancer Chemother Pharmacol 2001; 47: S45-S54(Suppl
3. Brun E, Nelson RG, Bennett PH et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000; 23: 1119-1123
4. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-1892
5. Donnan PT, Leese GP, Morris AD. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Taysicle, Scotland: a retrospective cohort study of resource use. Diabetes Care 2000; 23: 1774-1779
6. Feinstein AR. The role of observational studies in the evaluation of therapy. Stat Med 1984; 3: 341-346
7. Hauner H, van Ferber L, Köster I. Schätzungen der Diabeteshäufigkeit in der Bundesrepublik Deutschland anhand von Krankenkassendaten. Dtsch Med Wochenschr 1992; 117: 645-650
8. Hauner H, von Ferber L, Koster I. The outpatient care of diabetics. An analysis of the local compulsory medical insurance data from Dortmund. Dtsch Med Wochenschr 1994; 119: 129-134
9. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259
10. Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 1990; 89: 630-638
11. Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab Rev 1989; 5: 559-570
12. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Görtz A. Kosten des Typ-2-Diabetes in Deutschland: Ergebnisse der CODE-2-Studie. Dtsch Med Wochenschr 2001; 126: 585-589
13. Liebl A, Neiss A, Spannheimer A et al. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2 study. Exp Clin Endocrinol Diabetes 2002; 110: 10-16
14. Löwel H, Dinkel R, Hörmann A, Stieber J, Görtler E. Herzinfarkt und Diabetes: Ergebnisse der Augsburger Herzinfarkt-Follow-up Studie 1985 his 1990. Diab Stoffw 2003; 5: 19-23
15. Martin S, Kolb H, Scherbaum WA. Analysis of the impact of oral antidiabetic drugs on development of body weight by a retrolective trial a new form of non-biased retrospective clinical study design (Abstrakt). Diabetes 2003; 51 (Suppl 2); 433
16. Michaelis D, Jutzi E, Vogt L. Epidemiology of insulin-treated diabetes mellitus in the East-German population: differences in long-term trends between incidence and prevalence rates. Diabetes Metab 1993; 19: 110-115
17. Rathmann W, Haastert B, Roseman JM, Gries FA, Giani G. Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care 1998; 21: 389-397
18. Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189
19. Rothenbacher D, Ruter G, Saam S, Brenner H. VERSORGUNG VON Patienten mit Typ-2Diabetes: Ergebnisse aus 12 Hausarztpraxen. Dtsch Med Wochenschr 2002; 127: 1183-1187
20. Schneider B. Analysis of therapeutic efficacy in observational cohort studies. Cancer Chemother Pharmacol 2001; 47: S35-S37(Suppl
21. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23 (Suppl 2); B21-B29
22. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412
23. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865
24. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853